These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 24412084)
1. MicroRNA-137 down-regulates KIT and inhibits small cell lung cancer cell proliferation. Li P; Ma L; Zhang Y; Ji F; Jin F Biomed Pharmacother; 2014 Feb; 68(1):7-12. PubMed ID: 24412084 [TBL] [Abstract][Full Text] [Related]
2. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway. Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778 [TBL] [Abstract][Full Text] [Related]
4. Mitochondrial dysfunction rather than mtDNA sequence mutation is responsible for the multi-drug resistance of small cell lung cancer. Ma L; Wang R; Duan H; Nan Y; Wang Q; Jin F Oncol Rep; 2015 Dec; 34(6):3238-46. PubMed ID: 26502806 [TBL] [Abstract][Full Text] [Related]
5. Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by miR-200b contributes to multi-drug resistance of small cell lung cancer. Fang S; Zeng X; Zhu W; Tang R; Chao Y; Guo L Exp Mol Pathol; 2014 Jun; 96(3):438-44. PubMed ID: 24769353 [TBL] [Abstract][Full Text] [Related]
6. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2. Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992 [TBL] [Abstract][Full Text] [Related]
7. The human lung cancer drug resistance-related gene BC006151 regulates chemosensitivity in H446/CDDP cells. Li S; Shi H; Ji F; Wang B; Feng Q; Feng X; Jia Z; Zhao Q; Qian G Biol Pharm Bull; 2010; 33(8):1285-90. PubMed ID: 20686220 [TBL] [Abstract][Full Text] [Related]
8. Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A. Pan B; Chen Y; Song H; Xu Y; Wang R; Chen L Oncotarget; 2015 Jan; 6(1):317-31. PubMed ID: 25426560 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100. Xiao F; Bai Y; Chen Z; Li Y; Luo L; Huang J; Yang J; Liao H; Guo L Eur J Cancer; 2014 May; 50(8):1541-54. PubMed ID: 24559685 [TBL] [Abstract][Full Text] [Related]
10. [Involvement of bcl-2 in multidrug resistance in human small cell lung cancer cell subline H446/DDP]. Ji FY; Qian GS; Qian P; Chen Y; Guo RL; Li SP; Huang GJ Zhonghua Jie He He Hu Xi Za Zhi; 2006 Mar; 29(3):156-60. PubMed ID: 16677475 [TBL] [Abstract][Full Text] [Related]
11. Analysis of novel microRNA targets in drug-sensitive and -insensitive small cell lung cancer cell lines. Ma L; Li P; Wang R; Nan Y; Liu X; Jin F Oncol Rep; 2016 Mar; 35(3):1611-21. PubMed ID: 26676926 [TBL] [Abstract][Full Text] [Related]
12. miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro. Miao Y; Li J; Qiu X; Li Y; Wang Z; Luan Y Oncol Rep; 2013 Jan; 29(1):161-8. PubMed ID: 23117485 [TBL] [Abstract][Full Text] [Related]
13. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663 [TBL] [Abstract][Full Text] [Related]
14. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Zhu W; Shan X; Wang T; Shu Y; Liu P Int J Cancer; 2010 Dec; 127(11):2520-9. PubMed ID: 20162574 [TBL] [Abstract][Full Text] [Related]
15. Repression of linc01555 up-regulates angiomotin-p130 via the microRNA-122-5p/clic1 axis to impact vasculogenic mimicry-mediated chemotherapy resistance in small cell lung cancer. Li D; Shen Y; Ren H; Wang L; Yang J; Wang Y Cell Cycle; 2023 Jan; 22(2):255-268. PubMed ID: 36045598 [TBL] [Abstract][Full Text] [Related]
16. TSPAN12 promotes chemoresistance and proliferation of SCLC under the regulation of miR-495. Ye M; Wei T; Wang Q; Sun Y; Tang R; Guo L; Zhu W Biochem Biophys Res Commun; 2017 Apr; 486(2):349-356. PubMed ID: 28302484 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-21 increases cisplatin sensitivity of non-small-cell lung cancer. Xu L; Huang Y; Chen D; He J; Zhu W; Zhang Y; Liu X Cancer Genet; 2014 May; 207(5):214-20. PubMed ID: 24906642 [TBL] [Abstract][Full Text] [Related]
18. DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer. Cao J; Song Y; Bi N; Shen J; Liu W; Fan J; Sun G; Tong T; He J; Shi Y; Zhang X; Lu N; He Y; Zhang H; Ma K; Luo X; Lv L; Deng H; Cheng J; Zhu J; Wang L; Zhan Q Cancer Res; 2013 Jun; 73(11):3326-35. PubMed ID: 23592755 [TBL] [Abstract][Full Text] [Related]
19. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway. Wang R; Ma L; Weng D; Yao J; Liu X; Jin F Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-21 regulates the sensitivity to cisplatin in a human osteosarcoma cell line. Ziyan W; Yang L Ir J Med Sci; 2016 Feb; 185(1):85-91. PubMed ID: 25381586 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]